Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2Myeloid 2Lymphoid 2Classical hematology 2

Conditions

Lymphoma 201Precursor Cell Lymphoblastic Leukemia-Lymphoma 132Lymphoma, Non-Hodgkin 112Lymphoma, Large B-Cell, Diffuse 108Leukemia 106Lymphoma, Follicular 93Hodgkin Disease 92Burkitt Lymphoma 91Lymphoma, Mantle-Cell 87Leukemia, Lymphocytic, Chronic, B-Cell 84Lymphoma, Large-Cell, Immunoblastic 73Myelodysplastic Syndromes 63Leukemia, Myeloid, Acute 61Lymphoma, B-Cell, Marginal Zone 59Multiple Myeloma 48Dendritic Cell Sarcoma, Interdigitating 38Recurrence 33Leukemia, Myeloid, Chronic-Phase 33Myeloproliferative Disorders 32Leukemia, Myeloid, Accelerated Phase 32Neoplasms, Plasma Cell 28Blast Crisis 27Leukemia, Myelomonocytic, Chronic 25Lymphoma, Large-Cell, Anaplastic 22Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 21Waldenstrom Macroglobulinemia 20Myelodysplastic-Myeloproliferative Diseases 20Congenital Abnormalities 20Lymphoma, T-Cell, Cutaneous 19Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 19

Interventions

Cyclophosphamide 22fludarabine phosphate 19Whole-Body Irradiation 17Melphalan 16fludarabine 15Tacrolimus 14Busulfan 13Peripheral Blood Stem Cell Transplantation 11Mycophenolic Acid 11Alemtuzumab 8Methotrexate 6Antilymphocyte Serum 6Cyclosporine 5thymoglobulin 4Thiotepa 3Stem Cell Transplantation 3Methylprednisolone 3Granulocyte Colony-Stimulating Factor 3Etoposide 3AP 1903 reagent 3sargramostim 2Transplantation 2Sirolimus 2Rituximab 2Mesna 2Influenza Vaccines 2Immunoenzyme Techniques 2Hematopoietic Stem Cell Transplantation 2Flow Cytometry 2Filgrastim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Anemia, Aplastic × Filgrastim × Lymphoid × Clear all
NCT02960646 2023-02-16

Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

M.D. Anderson Cancer Center

Phase 1 Completed
11 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Blast Crisis, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01010217 2020-03-25

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

M.D. Anderson Cancer Center

Phase 2 Completed
176 enrolled 18 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hematologic Diseases, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡